Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K014137
    Manufacturer
    Date Cleared
    2002-01-16

    (30 days)

    Product Code
    Regulation Number
    888.3070
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    MODIFICATION TO EBI OMEGA 21 SYSTEM

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The EBI Omega 21™ System is a spinal fixation device for pedicle screw fixation and a non-pedicle hook and sacral/Iliac screw fixation system of the non-cervical spine.

    When used as a pedicle screw fixation system, in the non-cervical spine of skeletally mature patients, the System is intended to provide immobilization of spinal segments, as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine: Degenerative spondylolisthesis with objective evidence of nuerologic impairment, fracture, dislocations, scoliosis, kyphosis, spinal tumor, and failed previous fusion. (pseudoarthrosis).

    In addition, when used as a pedicle screw fixation system in skeletally mature patients, it is intended for patients: (a) having severe spondylolisthesis (Grades 3 and 4) of the fifth lumbar - first sacral (L5 - S1) vertebral joint; (b) who are receiving fusions using autogenous bone graft only; (c) who are having the device fixed or attached to the lumbar and sacral spine (1,3 and below); and (d) who are having the device removed after the development of a solid fusion mass.

    When used as a posterior hook and sacral/Iliac screw fixation system, the levels of attachment are the lumbar and thoracic spine, and screw fixation limited to the sacrum and ilium. The system is intended for the treatment of degenerative disk disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), pseudoarthrosis, stenosis, scoliosis, spondylolisthesis, fracture, previous failed fusion, or tumor resection.

    When used as an anterior fixation system, the levels of attachment are the anterolateral bodies of the lumbar and thoracic spine. The system is intended for the treatment of degenerative disk disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), pseudoarthrosis, scoliosis, spondylolisthesis, fracture, previous failed fusion, or tumor resection.

    Device Description

    The EBI Omega 21™ System is a spinal fixation device that uses rods, screws, couplers, and hooks. This submission is for the addition of top loading hooks to supplement the existing system. The components of the system are manufactured from Ti-6AI-4V ELI per ASTM F136.

    AI/ML Overview

    Here's an analysis of the provided text regarding the EBI Omega21™ System, focusing on acceptance criteria and the supporting study, structured according to your request:

    1. Table of Acceptance Criteria and Reported Device Performance

    The provided document (510(k) summary) does not explicitly state acceptance criteria or provide quantifiable device performance metrics in the typical sense of a diagnostic study. Instead, it focuses on demonstrating substantial equivalence to previously marketed devices. The "performance" assessment is based on mechanical testing to ensure the new component (top-loading hooks) meets functional requirements and applicable standards, implying that if it functions similarly and meets standards, it is acceptable.

    Acceptance Criteria (Implied)Reported Device Performance
    Material Compatibility: Components made from specified, biocompatible material.Components manufactured from Ti-6Al-4V ELI per ASTM F136.
    Functional Equivalence: New components (top-loading hooks) perform similarly to existing parts of the system and predicate devices."Testing comparing the modifications to the previous system demonstrated that the device complies with applicable standards and meets all of its functional requirements." (Explicitly stated for the modified components) "There are no significant differences between the EBI Omega 21™ System and other currently marketed spinal systems. It is substantially equivalent to the predicate devices in regards to intended use, materials and function."
    Compliance with Applicable Standards: The device meets relevant industry and regulatory standards for spinal fixation systems."Testing comparing the modifications to the previous system demonstrated that the device complies with applicable standards..."
    Intended Use Equivalence: The modified device can be used for the same clinical indications as predicate devices.The intended use statement for the EBI Omega 21™ System is provided and is considered substantially equivalent to predicate devices.
    Safety: The device modification does not introduce new safety concerns compared to predicate devices. (Implied by substantial equivalence and compliance with standards)Implicitly met by demonstrating functional equivalence, material standards, and "no significant differences" from predicate devices which are already deemed safe.

    2. Sample Size Used for the Test Set and Data Provenance

    The provided document does not describe a clinical "test set" in the context of diagnostic performance evaluation with patient data. The "testing" mentioned refers to mechanical and functional testing of the new top-loading hooks. The sample size for such mechanical tests is not specified, nor is the provenance of data as it pertains to patient or clinical outcomes. This is a 510(k) for a medical device (spinal fixation system), not a diagnostic algorithm.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    This information is not applicable to this document. The "ground truth" for a mechanical device is its specifications, design, and adherence to engineering principles and standards, not clinical expert consensus on patient data.

    4. Adjudication Method for the Test Set

    This information is not applicable to this document. Adjudication methods (like 2+1, 3+1) are used in clinical studies with human readers or evaluators, not for mechanical device testing where performance is often measured by objective engineering metrics.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance

    This information is not applicable to this document. This is a submission for a spinal fixation device, not an AI or diagnostic imaging tool. There is no mention of AI assistance or human reader studies.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) Was Done

    This information is not applicable to this document. This is a medical device, not an algorithm.

    7. The Type of Ground Truth Used

    The "ground truth" for this device's performance, as implied by the document, is based on:

    • Engineering specifications and standards: ASTM F136 for materials.
    • Functional requirements: Demonstrated through "testing comparing the modifications to the previous system."
    • Regulatory compliance: Adherence to FDA requirements for spinal fixation devices.
    • Substantial equivalence: Comparison to predicate devices already established as safe and effective.

    No pathology, expert consensus, or outcomes data is mentioned as a "ground truth" for this specific 510(k) submission.

    8. The Sample Size for the Training Set

    This information is not applicable to this document. "Training set" refers to data used to train algorithms, which is not relevant here.

    9. How the Ground Truth for the Training Set Was Established

    This information is not applicable to this document.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1